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he WD-repeat proteins Rae1 and Bub3 show exten-
sive sequence homology, indicative of functional
similarity. However, previous studies have suggested
that Rae1 is involved in the mRNA export pathway and
Bub3 in the mitotic checkpoint. To determine the in vivo
roles of Rae1 and Bub3 in mammals, we generated knock-
out mice that have these genes deleted individually or in
combination. Here we show that haplo-insufﬁciency of either
Rae1 or Bub3 results in a similar phenotype involving mitotic
checkpoint defects and chromosome missegregation. We also
show that overexpression of Rae1 can correct for Rae1 haplo-
insufﬁciency and, surprisingly, Bub3 haplo-insufﬁciency.
Rae1-null and Bub3-null mice are embryonic lethal, although
T
 
cells from these mice did not have a detectable defect in
nuclear export of mRNA. Unlike null mice, compound
haplo-insufﬁcient Rae1/Bub3 mice are viable. However,
cells from these mice exhibit much greater rates of premature
sister chromatid separation and chromosome missegregation
than single haplo-insufﬁcient cells. Finally, we show that
mice with mitotic checkpoint defects are more susceptible
to dimethylbenzanthrene-induced tumorigenesis than
wild-type mice. Thus, our data demonstrate a novel function
for Rae1 and characterize Rae1 and Bub3 as related proteins
with essential, overlapping, and cooperating roles in the
mitotic checkpoint.
 
Introduction
 
Abnormalities of chromosome number are a hallmark of the
vast majority of human cancers, but little is known about
the genetic events that can initiate or promote losses or gains
of whole chromosomes (Hartwell and Kastan, 1994; Lengauer
et al., 1998; Cahill et al., 1999b). In a subset of human cancers
with chromosomal instability, mutations have been identified
in genes that encode mitotic checkpoint proteins, such as
Bub1, BubR1, and Mad2 (Cahill et al., 1998; Imai et al.,
1999; Gemma et al., 2001). The mitotic checkpoint is a
partly resolved intricate molecular network that helps to ensure
faithful segregation of duplicated chromosomes during mitosis
(Burke, 2000; Shah and Cleveland, 2000; Kitagawa and
Hieter, 2001; Nigg, 2001; Wassmann and Benezra, 2001).
Kinetochores of chromosomes that are not yet aligned at the
metaphase plate and attached to microtubules activate the
mitotic checkpoint, leading to inhibition of the anaphase-
promoting complex (APC)* (Morgan, 1999; Peters, 2002).
When all kinetochores are attached to microtubules and the
chromosomes are aligned at the metaphase plate, the check-
point is released. The APC then enables the onset of anaphase
by activation of the protease separase, which separates sister
chromatids by cleaving cohesion complexes (Peters, 2002).
During prophase and prometaphase, mitotic checkpoint
proteins are positioned in the mitotic cytosol and at the kineto-
chores of condensed chromosomes. Current models propose
that checkpoint proteins associated with kinetochores act as
sensors for microtubule–kinetochore attachment and kineto-
chore tension. In the absence of attachment or tension, they
act to generate a molecular “anaphase wait” signal (Shah and
Cleveland, 2000; Hoffman et al., 2001; Jallepalli and Lengauer,
2001). Although the composition of this signal is unclear, it
is believed to activate mitotic checkpoint proteins in the mitotic
cytosol, including BubR1, Bub3, and Mad2 (Fang et al.,
 
Address correspondence to Jan van Deursen, Mayo Clinic, 200 First
Street SW, Rochester, MN 55905. Tel.: 507-284-2524. Fax: 507-266-
0340. E-mail: vandeursen.jan@mayo.edu
Key words: mRNA export; Rae1/Gle2; Bub3; mitotic checkpoint; chro-
mosomal instability
 
*Abbreviations used in this paper: APC, anaphase-promoting complex;
E, embryonic day; ES, embryonic stem; ICM, inner cell mass; MEF,
mouse embryonic fibroblast; NE, nuclear envelope; NPC, nuclear pore
complex; PMSCS, premature sister chromatid separation.T
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1998; Gillett and Sorger, 2001; Hoyt, 2001; Sudakin et al.,
2001; Fang, 2002; Yu, 2002). Activated checkpoint pro-
teins then bind to Cdc20, thereby preventing it from acti-
vating the APC. When a chromosome has proper microtu-
bule–kinetochore attachment and kinetochore tension, its
kinetochore-associated checkpoint proteins partially detach
and its emission of anaphase wait signals stops. Alignment
of all chromosomes at the metaphase plate quenches all
anaphase wait signals, allowing Cdc20 to bind to and acti-
vate the APC.
The mitotic checkpoint protein Bub3 shares extensive se-
quence homology with Rae1 (Taylor et al., 1998; Martinez-
Exposito et al., 1999). Their homology is not confined to
each of the four WD repeat motifs; it extends over the entire
protein length and is especially high in the segment that sep-
arates WD repeats 3 and 4. Rae1 (also called Gle2 or
mrnp41) is a highly conserved nuclear transport factor that
is involved in the pathway for mRNA export in interphase,
but whose precise role remains unclear (Brown et al., 1995;
Murphy et al., 1996; Kraemer and Blobel, 1997; Taylor and
McKeon, 1997; Bailer et al., 1998; Martinez-Exposito et al.,
1999; Pritchard et al., 1999; Bachi et al., 2000; Yoon et al.,
2000; Zenklusen et al., 2001). The nucleoporin Nup98
contains a motif named GLEBS that directs binding to
Rae1 (Pritchard et al., 1999). We have recently shown that
GLEBS motifs are also present in the mitotic checkpoint
proteins Bub1 and BubR1, where they serve as binding sites
for Bub3 (Wang et al., 2001). Bub3 exclusively binds to
GLEBS sequences of mitotic checkpoint proteins. However,
Rae1 binds not only to Nup98 but also to Bub1 (Wang et
al., 2001). This finding led us to hypothesize that Rae1
might act as a mitotic checkpoint protein. To test this hy-
pothesis, we have disrupted the mouse Rae1 gene by homol-
ogous recombination. We show that the loss of a single
Rae1 allele causes a mitotic checkpoint defect and chromo-
some missegregation.
 
Results
 
Rae1 is essential for early embryogenesis
 
We addressed the physiological role of Rae1 through a gene-
targeting approach in the mouse. We inactivated the Rae1
gene by interrupting its coding region at amino acid 50 with
a lacZ-neo selection cassette (Fig. 1 A). Three independently
targeted embryonic stem (ES) cell clones yielded chimeric
mice that passed the disrupted Rae1 gene through the germ-
line (Fig. 1 B). These Rae1 heterozygous mice were indistin-
guishable from wild-type littermates. We intercrossed het-
erozygous mice but found no Rae1
 
 
 
/
 
 
 
 mice among 203
liveborn offspring, demonstrating that Rae1 is essential for
mouse embryogenesis.
To determine when Rae1
 
 
 
/
 
 
 
 embryos die, we collected
embryos from heterozygous intercrosses at various stages of
development and genotyped them by a PCR method (Fig.
1, A and C). Dissection of embryos at 8.5 d post-coitum
(embryonic day [E]8.5) yielded 9 Rae1
 
 
 
/
 
 
 
, 22 Rae1
 
 
 
/
 
 
 
, but
no Rae1
 
 
 
/
 
 
 
 embryos. At 3.5 d of gestation, however,
Rae1
 
 
 
/
 
 
 
 embryos were present at a normal Mendelian fre-
quency (7 
 
 
 
/
 
 
 
, 13 
 
 
 
/
 
 
 
, and 6 
 
 
 
/
 
 
 
 embryos were identi-
fied among 26 blastocysts). These Rae1
 
 
 
/
 
 
 
 embryos were
 
morphologically indistinguishable from their wild-type and
heterozygous counterparts.
To further investigate the developmental defects caused by
Rae1 depletion, we harvested blastocysts from heterozygous
intercrosses at E3.5 and then analyzed their in vitro growth
properties (van Deursen et al., 1996). Regardless of the geno-
type, most cultured blastocysts hatched from the zona pellu-
cida and attached to the surface of the tissue culture dish dur-
ing the first 2 d of culture (Fig. 1 D). From E6.5 through
E8.5, cultured Rae1
 
 
 
/
 
 
 
 and Rae1
 
 
 
/
 
 
 
 blastocysts rapidly ex-
panded their inner cell mass (ICM) on an underlying sheet of
post-mitotic trophoblast cells (Fig. 1 D). We observed ICMs
shortly after attachment of Rae1
 
 
 
/
 
 
 
 blastocysts at E5.5, but
these masses failed to expand from E6.5 through E8.5 and,
instead, degenerated (34 out of 144 embryos degenerated).
On the other hand, the trophoblast cells from Rae1
 
 
 
/
 
 
 
 blas-
tocysts developed normally into a flattened layer and re-
mained viable up to and beyond E8.5 (Fig. 1 D).
 
Rae1 is not essential for nuclear export of mRNA
 
The ability to culture Rae1
 
 
 
/
 
 
 
 blastocysts allowed us to fur-
ther investigate the role of Rae1 in nucleocytoplasmic trans-
port (Fig. 2 A). First, we double stained E7.5–E8.5 em-
bryonic outgrowths with a polyclonal antibody against
mouse Rae1(188–368) and monoclonal antibody mAb414,
a marker of the nuclear pore complex (NPC) (Wu et al.,
2001). In cells from control embryonic outgrowths, Rae1
prominently localized to the nuclear envelope (NE), al-
though significant amounts of Rae1 were also found in the
nucleus and the cytoplasm (Fig. 2 B). No Rae1 staining was
detected in cells from Rae1
 
 
 
/
 
 
 
 outgrowths, confirming that
our gene-targeting strategy had indeed generated a null allele
(Fig. 2 C). Disruption of the Rae1 homologue 
 
GLE2
 
 in 
 
Sac-
charomyces cerevisiae
 
 causes severe clustering of nuclear pores
(Murphy and Wente, 1996). Rae1-depleted cells showed a
strong and uninterrupted rim-like labeling of the NE with
mAb414, similar to that of control cells (Fig. 2 C
 
 
 
), indicat-
ing that knockout cells have a normal distribution of NPCs.
Another feature of Gle2p-deficient yeast cells is the forma-
tion of membranous structures that seal nuclear pores (Mur-
phy and Wente, 1996). Examination of embryonic out-
growths by transmission electron microscopy demonstrated
that NPC sealing does not occur in Rae1
 
 
 
/
 
 
 
 cells (unpub-
lished data). Nup98, a nucleoporin that forms a complex
with Rae1 at the NPC (Pritchard et al., 1999), exhibited a
pronounced NE localization in Rae1
 
 
 
/
 
 
 
 embryos (Fig. 2, D
and E), demonstrating that Rae1 is not needed for binding
of Nup98 to NPCs.
Because previous studies have linked Rae1 to the pathway
for nuclear export of mRNA (Brown et al., 1995; Murphy et
al., 1996; Kraemer and Blobel, 1997; Pritchard et al., 1999;
Bachi et al., 2000; Sabri and Visa, 2000), we asked whether
cells lacking this protein accumulate mRNA in their nuclei.
E8.5 embryonic outgrowths from heterozygous intercrosses
were stained for poly(A)
 
 
 
 RNA by an in situ hybridization
technique using FITC-labeled oligo(dT)
 
50
 
-mer probe (Prit-
chard et al., 1999). Surprisingly, both the level and the sub-
cellular distribution of poly(A)
 
 
 
 RNA appeared normal in
cells of Rae1-deficient embryonic outgrowths (Fig. 2, F and
G). Similar results were obtained when earlier embryonicT
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Haplo-insufficiency at the Rae1 locus causes mitotic 
checkpoint dysfunction
 
Because Rae1 has a high degree of sequence similarity to
Bub3 and can interact with Bub1 (Taylor et al., 1998; Mar-
tinez-Exposito et al., 1999; Wang et al., 2001), it was of in-
terest to determine whether Rae1 would be required in mito-
sis. Others have recently shown that HCT116 cells with only
one copy of the mitotic checkpoint gene Mad2 fail to arrest
in prometaphase and exit mitosis without cytokinesis when
cultured in the presence of the microtubule-depolymerizing
drug nocodazole (Michel et al., 2001), a response that is typ-
ical for cells with a defective mitotic checkpoint (Wassmann
and Benezra, 2001). This information prompted us to ana-
Figure 1. Targeted disruption of the mouse Rae1 gene. (A) Indicated are part of the endogenous mouse (m)Rae1 gene (top), the targeting 
vector (middle), and the disrupted Rae1 allele (bottom). BamHI restriction sites and the 3  DNA probe (solid bar) used for Southern blot 
identification of wild-type (WT) and knockout (KO) Rae1 alleles are shown. (B) Southern blot of genomic ES cell DNA, digested with BamH1 
and hybridized to a 3  external probe, revealing the expected 10.2-kb wild-type and 8.5-kb mutant fragments. (C) PCR genotyping of E3.5 
embryos from a Rae1
 /  intercross showing wild-type and knockout allele-specific amplification products of respectively 516 and 650 bp. 
(D) In vitro growth of representative Rae1
 /  and Rae1
 /  embryos. Embryos from heterozygous crosses were recovered at E3.5 and grown on 
multi-well slides in DME/15% FCS. They were inspected daily and photographed at 48 (E5.5), 72 (E6.5), and 96 h (E7.5) after seeding. I, ICM; 
T, trophectoderm cells.
 
outgrowths (E5.5–E7.5) were stained for poly(A)
 
 
 
 RNA
(unpublished data), revealing that ICM degeneration does
not coincide with nuclear accumulation of mRNA. We also
asked if the subcellular distribution of various pre-mRNA/
mRNA binding proteins would be altered in the absence of
Rae1. Immunolabeling experiments with antibodies against
the mRNA export factors Tap (Fig. 2, H and I) and Aly, the
hnRNP proteins A and C2, the SR protein SC35, and the
splicing-dependent mRNA-binding protein Y14 showed
normal subcellular localizations for all these proteins in
Rae1
 
 
 
/
 
 
 
 cells (unpublished data). Thus, it appears that the
bulk of mRNAs synthesized in the nucleus can be exported
to the cytoplasm when Rae1 is lacking.T
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lyze the response of Rae1 haplo-insufficient cells to nocoda-
zole. We first intercrossed heterozygous mice to derive
Rae1
 
 
 
/
 
 
 
 and Rae1
 
 
 
/
 
 
 
 mouse embryonic fibroblasts (MEFs)
from individual 13.5-d-old fetuses. These MEFs were frozen
at passages 2 and 3 and used for experimentation at passage 4
or 5. For the studies described below, at least three Rae1
 
 
 
/
 
 
 
and three Rae1
 
 
 
/
 
 
 
 clones were examined.
Western blot analysis revealed that the amount of Rae1
protein in Rae1
 
 
 
/
 
 
 
 cells was consistently lower than in
Rae1
 
 
 
/
 
 
 
 cell lines (Fig. 3 A); additional tests showed that
Bub3 and Mad2 protein levels were similar in Rae1
 
 
 
/
 
 
 
 and
Rae1
 
 
 
/
 
 
 
 cells (Fig. 3 A). Growth rate measurements showed
that the reduction of Rae1 protein had no significant impact
on the rate of cell proliferation (Fig. 3 B). We then mea-
sured the response of the Rae1 haplo-insufficient cells to
spindle damage. We treated cells with 200 ng/ml nocodazole
for 0, 2, 6, 12, or 24 h, stained with phospho-histone H3
antibody to identify mitotic cells, and then measured the
mitotic index (defined as the percentage of mitotic cells) at
each time point using fluorescence microscopy. We found
that 15% of Rae1
 
 
 
/
 
 
 
 cells were arrested by 12 h (Fig. 3 C).
In contrast, only 2.5% of haplo-insufficient cells were ar-
rested at that time point, indicating that their mitotic check-
point was defective. Consistent with this observation,
Rae1
 
 
 
/
 
 
 
 cultures accumulated far fewer rounded cells in the
presence of nocodazole than Rae1
 
 
 
/
 
 
 
 cultures (Fig. 3 D).
To confirm and extend these analyses, we examined cells
by flow cytometry. Unsynchronized Rae1
 
 
 
/
 
 
 
 and Rae1
 
 
 
/
 
 
 
MEFs had similar DNA profiles (Fig. 3 E, 1 and 4). Expo-
sure to nocodazole for 12 h resulted in accumulation of cells
with 4N DNA content irrespective of the genotype (Fig. 3
E, 2 and 5). When cells were allowed to recover in medium
without nocodazole for 4 h, the DNA profile of Rae1
 
 
 
/
 
 
 
MEF cells quickly returned to normal as mitotically-arrested
cells were able to complete their mitosis and enter G1 phase
with 2N DNA content (Fig. 3 E, 3). In contrast, the DNA
profile of Rae1
 
 
 
/
 
 
 
 MEF cells showed only limited recovery
(Fig. 3 E, 6), indicating that Rae1
 
 
 
/
 
 
 
 cells that entered mito-
sis in the presence of nocodazole had exited from mitosis
prematurely without dividing to produce a cell in G1 that
contained 4N DNA content. When the recovery phase was
extended to 12 h, essentially the same profile was obtained
as with the 4-h recovery (unpublished data).
To further verify the loss of mitotic checkpoint activity,
we measured the cyclin B–associated Cdc2 kinase activity of
MEFs that were synchronized in G1 by low serum, released
into medium with high serum and nocodazole, and collected
 
Figure 2.
 
Rae1 is not essential for nuclear export of mRNA.
 
 
(A) Overview of the experimental design. Blastocysts from intercrosses 
of Rae1
 
 
 
/
 
 
 
 mice were cultured for 
 
 
 
4–5 d and then analyzed by 
 
immunostaining or in situ hybridization. (B–C’) Double staining of 
E8.5 embryonic outgrowths with a polyclonal antibody against 
mouse Rae1(188–368) (Pritchard et al., 1999) and monoclonal 
antibody mAb414, a marker of the NPC (Wu et al., 2001). Shown 
are representative high-resolution images of trophectoderm cells. 
(D and E) Immunostaining of E8.5 embryonic outgrowths with a 
polyclonal antibody against Nup98(151–224) (Wu et al., 2001). 
Shown are high-resolution images of trophectoderm cells. 
(F and G) Localization of poly(A)
 
 
 
 RNA in trophectoderm cells from 
E8.5 Rae1
 
 
 
/
 
 
 
 and Rae1
 
 
 
/
 
 
 
 outgrowths. A FITC–oligo(dT)
 
50
 
 probe 
was used for visualization of poly(A)
 
 
 
 by in situ hybridization. 
(H and I) Trophoblast cells stained with a polyclonal antibody against 
human Tap (Braun et al., 1999).T
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at various time points (Wassmann and Benezra, 1998;
Michel et al., 2001). At 24 h after release in nocodazole,
both Rae1
 
 
 
/
 
 
 
 and Rae1
 
 
 
/
 
 
 
 cultures showed a high level of
Cdc2 kinase activity (indicating that the synchronized cul-
tures had reached M phase; Fig. 3 F). Whereas Rae1
 
 
 
/
 
 
 
 cul-
tures maintained a high level of Cdc2 kinase activity until at
least 42 h after release, Rae1
 
 
 
/
 
 
 
 cultures showed a marked
decline in kinase activity after 30 h, confirming that Rae1
Figure 3. The mitotic checkpoint requires a full complement of Rae1. (A) Analysis of Rae1
 /  and Rae1
 /  MEF lines for Rae1, Bub3, and 
Mad2 protein levels by Western blotting (4–20% polyacrylamide gel). 100  g of total protein extract from each MEF cell line was used in the 
analysis. For probes, we used a rabbit antibody against mouse Rae1(188–368), a rabbit antibody against mouse Bub3(145–276), and a mouse 
monoclonal antibody against human Mad2 that recognizes mouse Mad2 (BD Biosciences). (B) Growth curves of primary MEFs. Data shown 
are means and standard deviations derived from three Rae1
 /  and three Rae1
 /  MEF lines. (C) Mitotic index of nocodazole-treated Rae1
 /  
and Rae1
 /  MEF cell lines (n   3 for each genotype). (D) Representative phase contrast images of Rae1
 /  and Rae1
 /  MEF cultures before 
and after 4 h of nocodazole exposure. (E) Representative FACS
® profiles of propidium-stained unsynchronized Rae1
 /  (panels 1–3) and 
Rae1
 /  MEFs (panels 4–6). Durations of nocodazole treatment (80 ng/ml) and recovery intervals are indicated. (F) Cyclin B–associated Cdc2 
kinase activity of synchronized MEF cells at indicated time points after release into nocodazole.T
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haplo-insufficient cells fail to arrest in mitosis in response to
spindle damage. Taken together, the above analyses strongly
suggest that the mitotic checkpoint is defective in Rae1
haplo-insufficient cells.
 
Rae1 haplo-insufficiency promotes 
chromosome missegregation
 
Next, we determined the effect of Rae1 haplo-insufficiency
on chromosome number stability by performing chromo-
some counts on metaphase spreads from Rae1
 
 
 
/
 
 
 
 and Rae1
 / 
MEFs at passage 5. The average percentage of aneuploid
metaphases was significantly higher in Rae1
 /  MEFs than in
Rae1
 /  MEFs (20   2% vs. 9   1%; Fig. 4 A; see also Fig.
8, B and D). In addition, Rae1
 /  spreads showed a broader
spectrum of abnormal chromosome numbers than Rae1
 / 
spreads (Fig. 4 B; see also Fig. 8, B and D). Together, these
findings show that loss of a single Rae1 allele leads to a signif-
icantly increased rate of chromosome missegregation.
Bub3 haplo-insufficiency causes mitotic checkpoint 
failure and chromosome missegregation
We then asked whether a haplo-insufficiency at the Bub3 lo-
cus would also cause a mitotic phenotype. We inactivated
the mouse Bub3 gene by interrupting its coding region at
amino acid 191 via homologous recombination (Fig. 5, A
and B). Bub3
 /  mice were indistinguishable from wild-
type littermates (unpublished data). Like Rae1
 /  inter-
crosses, Bub3
 /  intercrosses yielded no Bub3
 /  mice at
birth and at day 8.5 of embryogenesis, but produced Bub3
 / 
blastocysts at a Mendelian frequency (unpublished data).
The growth abnormalities of these Bub3-deficient blasto-
cysts (unpublished data) were similar to those of Rae1
 / 
blastocysts (Fig. 1 D) and Bub3
 /  blastocysts from an ear-
lier study (Kalitsis et al., 2000). In situ hybridization experi-
ments on E8.5 outgrowths confirmed that disruption of
Bub3 had no impact on the localization and level of
poly(A)
  RNA in the cell (unpublished data).
We collected E13.5 embryos from Bub3
 /  intercrosses
and generated Bub3
 /  and Bub3
 /  MEF lines from indi-
vidual embryos. Bub3 protein levels were consistently lower
in Bub3
 /  MEFs than in Bub3
 /  MEFs (Fig. 5 C), but
this reduction did not affect cell growth (unpublished data).
Consistent with a loss of mitotic checkpoint activity, the mi-
totic index of Bub3
 /  cultures was not much increased in
the presence of nocodazole (Fig. 5, D and E). DNA profile
analysis confirmed that nocodazole-exposed Bub3
 /  cells
leave mitosis prematurely without undergoing cytokinesis
(Fig. 5 F). Furthermore, as expected, the cyclin B–associated
Cdc2 kinase activity of synchronized MEFs that were re-
leased in nocodazole declined much faster in Bub3
 /  cells
than in Bub3
 /  cells (Fig. 5 G).
Next, we determined whether Bub3 haplo-insufficiency
affects the fidelity of chromosome segregation in M phase.
Chromosome counts on metaphase spreads revealed that the
percentage of aneuploid cells was significantly higher in
Bub3
 /  cultures than in Bub3
 /  cultures (21   2% vs.
9   3%; Fig. 6 A; see also Fig. 8, B and D). Like Rae1
 / 
spreads, Bub3
 /  spreads displayed a broader spectrum of
nonmodal chromosome numbers than control spreads (Fig.
6 B; see also Fig. 8, B and D). Collectively, these studies re-
veal that the loss of a single Bub3 allele perturbs the mitotic
checkpoint and establishes a higher rate of chromosome
number instability.
Overexpression of Rae1 rescues the checkpoint defect 
of Bub3 haplo-insufficient cells
Next, we cloned HA epitope–tagged mouse Rae1 cDNA into
the pMSCV-Puro retroviral vector and used it to test whether
ectopic expression of Rae1 would be able to correct for (a)
Rae1 haplo-insufficiency (which would be expected if the mi-
totic phenotype is a direct consequence of the Rae1 mutation)
and (b) Bub3
 /  haplo-insufficiency (which would indicate
that Rae1 has functional overlap with Bub3). We introduced
the HA–Rae1 expression vector into two Rae1
 /  and two
Bub3
 /  MEF lines by retroviral gene transfer (Kasper et al.,
1999), selected the cultures for puromycin-resistant cells, and
tested these cells for their ability to activate the mitotic check-
point in response to nocodazole-induced spindle damage.
Consistent with a reestablishment of normal mitotic check-
point activity, the mitotic index of HA–Rae1-expressing
Rae1
 /  cultures showed a similar increase as Rae1
 /  cul-
tures (Fig. 7 A). As expected, Rae1
 /  cells transduced with
empty pMSCV-Puro vector remained unable to sustain their
mitotic checkpoint activity. Strikingly, HA–Rae1 was also ca-
Figure 4. Rae1 haplo-insufficient cells 
exhibit increased chromosomal instability. 
(A) Analysis of the percentage of aneuploid 
cells in MEF cultures at passage 5. Values 
are from three independent Rae1
 /  and 
three independent Rae1
 /  MEF cultures. 
50 metaphases were counted for each MEF 
line. (B) Distribution of chromosome numbers 
of wild-type and Rae1 haplo-insufficient 
MEF lines. Data shown are combined 
values from three independent MEF lines 
per genotype.T
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Figure 5. Disruption of a single Bub3 allele leads to mitotic checkpoint dysfunction. (A) Targeted inactivation of the mouse Bub3 gene. 
Shown is part of the endogenous mouse (m)Bub3 gene (top), the targeting vector (middle), and the disrupted mBub3 allele (bottom). BamHI 
restriction sites and the 5  DNA probe (solid bar) used for Southern blot identification of wild-type (WT) and knockout (KO) Bub3 alleles are 
indicated. (B) Southern blot of genomic mouse tail DNA, digested with BamH1 and hybridized to a 5  external probe, revealing the expected 
7-kb wild-type and 5.5-kb mutant bands. (C) Western blot analysis of Bub3 protein levels in Bub3
 /  and Bub3
 /  MEF lines using an antibody 
to mouse Bub3(145–276) (Wang et al., 2001). (D) Mitotic index of nocodazole-treated Bub3
 /  and Bub3
 /  MEF cell lines. (E) Images of 
Bub3
 /  and Bub3
 /  MEF cultures before and after nocodazole treatment. (F) DNA contents of asynchronous Bub3
 /  (panels 1–3) and 
Bub3
 /  cells (panels 4–6) after the indicated treatments. (G) Cyclin B–associated Cdc2 kinase activity of synchronized MEF cultures at 
indicated time points after release into nocodazole.T
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pable of restoring the mitotic checkpoint defect caused by re-
duced Bub3 activity (Fig. 7 B). Thus, Rae1 can compensate
for Bub3-mediated mitotic checkpoint activity that is affected
by limited availability of Bub3 molecules.
Combined Rae1 and Bub3 haplo-insufficiency 
accelerates genetic instability
To further define the roles of Rae1 and Bub3 in mitosis, we
analyzed the combined effects of Rae1 and Bub3 haplo-
insufficiency. We found that crosses of Rae1
 /  and Bub3
 / 
mice led to normal numbers of Rae1/Bub3 double heterozy-
gous mice (53 among 214 total offspring). These compound
heterozygotes had a normal appearance and displayed no re-
duction in body mass (unpublished data). MEFs were pre-
pared from crosses of Rae1
 /  and Bub3
 /  mice. Double
haplo-insufficient MEFs grew significantly slower than wild-
type and single heterozygous MEFs (Fig. 8 A). Furthermore,
chromosome counts at passage 5 revealed that the percent-
age of aneuploid cells in double haplo-insufficient cultures
had increased by 32% relative to wild-type cultures (Fig. 8
B). This was significantly higher than the 10% increases
measured in corresponding Rae1 and Bub3 single haplo-
insufficient cultures (Fig. 8 B). Notably, the range of non-
modal chromosome numbers was much larger in double
heterozygous cells than in single heterozygous cells, which in
turn had a broader spectrum than wild-type cells (Fig. 8, B
and D). We observed prematurely separated sister chroma-
tids in  19% of mitotic figures from double haplo-insuffi-
cient cells, but essentially none in mitotic figures from single
haplo-insufficient cells (Fig. 8, B and C). In addition, the
percentage of anaphase figures with lagging chromosomes
was much higher in Rae1
 / /Bub3
 /  cells (15%) than in
Rae1
 /  (5%) or Bub3
 /  (5%) cells, which in turn had a
higher percentage than wild-type cells (2%) (n    200
anaphases per genotype).
To investigate the degree of chromosomal instability in
adult mice, we collected splenocytes from 5-mo-old wild-
type, Rae1
 / , Bub3
 / , and Rae1
 / /Bub3
 /  mice (n   3
mice per genotype) and prepared metaphase spreads (Fig. 8
E). No aneuploidy was observed in wild-type splenocytes. In
contrast, 9% of Rae1
 /  and Bub3
 /  splenocytes and 37%
of Rae1
 / /Bub3
 /  splenocytes showed aneuploidy. Fur-
thermore, prematurely separated sister chromatids were
present in 13% of mitotic figures from Rae1
 / /Bub3
 / 
mice. As expected, the other genotypes did not show this
defect. Therefore, combined haplo-insufficiency of Rae1
and Bub3 accelerates chromosomal instability in cultured
cells and mice.
Figure 6. Bub3
 /  cells display increased 
chromosome number instability. (A) Analysis of the 
degree of aneuploidy in MEF cultures at passage 5. 
Values are from three independent Bub3
 /  and 
three independent Bub3
 /  MEF cultures. 50 
metaphase spreads were counted for each MEF 
culture. (B) Distribution of chromosome numbers 
of wild-type and Bub3 haplo-insufficient MEF lines 
(combined values of each genotype).
Figure 7. HA–Rae1 expression restores mitotic checkpoint 
activation in both Rae1 and Bub3 haplo-insufficient cells. (A) Mitotic 
index of nocodazole-treated Rae1
 / /empty vector (n   2) and 
Rae1
 / /HA–Rae1 (n   2) cell lines. (B) Mitotic index of nocodazole-
treated Bub3
 / /empty vector (n   2) and Bub3
 / /HA–Rae1 (n   2) 
cell lines. Note that HA–Rae1-expressing cultures accumulate 
mitotic cells over time, illustrating that their mitotic checkpoint 
activity is restored.T
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Increased tumor formation in mice 
with chromosomal instability
To determine whether single and double haplo-insufficient
mice have increased susceptibility to carcinogen-induced tu-
morigenesis, we gave pups from Rae1
 /  x Bub3
 /  inter-
crosses a single application of 50  l of a solution of 0.5%
DMBA in acetone to the dorsal surface on post-natal day 5
(Serrano et al., 1996). 5 mo after DMBA treatment, the
mice were killed and screened for tumor formation. Irrespec-
tive of the mouse genotype, tumors were exclusively detect-
able in the lungs (Fig. 9 A). In Rae1
 / , Bub3
 / , and
Rae1
 / /Bub3
 /  mice, the incidence of lung tumors was
increased compared with their wild-type counterparts (Fig. 9
B), as was the average number of tumors per treated animal
(Fig. 9 C). As controls, we examined 10 nontreated 5-mo-
old mice per genotype for spontaneous tumors. No tumors
were found in the wild-type, Rae1
 / , or Bub3
 /  mice,
whereas 1 of the 10 Rae1
 / /Bub3
 /  mice had a lung tu-
mor. Taken together, the above data indicate that mitotic
checkpoint–defective mice are predisposed to chemical-
induced lung tumorigenesis. We are monitoring over 50
mice per genotype (currently ranging in age from 2 to 7 mo)
for possible development of spontaneous tumors as they age.
Discussion
Rae1 and global mRNA export
Although inactivating mutations in the Schizosaccharomyces
pombe and S. cerevisiae homologues of Rae1 cause nuclear
accumulation of poly(A)
  RNA (Brown et al., 1995; Mur-
phy et al., 1996), similar genetic experiments in mice do
not induce such a defect, indicating that Rae1 is not essen-
tial for bulk mRNA export in mammalian cells. Consistent
with this finding, no nuclear accumulation of poly(A)
 
RNA occurs in human cells in which Rae1 expression is de-
pleted by RNA interference (E. Izaurralde, personal com-
munication). The most straightforward interpretation of
the combined data would be that Rae1 is not implicated in
mRNA export in higher eukaryotes. However, the previous
observation that overexpression of the GLEBS motif of
Nup98 (a motif that binds to and inhibits Rae1) results in
nuclear accumulation of poly(A)
  RNA in HeLa cells (Prit-
chard et al., 1999) argues for a role of Rae1 in the mamma-
lian mRNA export pathway. One attractive possibility is
that Rae1 is an mRNA export factor that can be compen-
sated for by another transport factor when it is absent. Per-
haps such compensatory action may not be possible when
Rae1 is present in the cell as a Rae1–GLEBS complex.
Figure 8. Rae1 synergizes with Bub3 in the development of 
aneuploidy. (A) Growth curves of MEFs derived from wild-type, 
Rae1
 / , Bub3
 / , and Rae1
 / /Bub3
 /  13.5-d-old embryos (all 
harvested from Rae1
 /  x Bub3
 /  intercrosses). Data shown are 
means and standard deviations derived from three independent MEF 
lines per genotype. (B) Chromosome analysis of MEFs (at passage 5) 
from 13.5-d-old embryos collected from Rae1
 /  females that were 
fertilized by Bub3
 /  males. Data shown are means and standard 
deviations derived from three independent MEF lines per genotype. 
We counted the chromosomes of 50 metaphase spreads per independent MEF line. 200 mitotic figures per MEF line were screened for premature 
sister chromatid separation (PMSCS). (C) Metaphase spreads showing sister chromatid cohesion in a wild-type MEF (left) and PMSCS in a 
double heterozygote MEF (right). (D) Comparison of chromosome number distributions between wild-type, single heterozygous, and double 
heterozygous MEF lines (combined values of each genotype). (E) Aneuploidy and PMSCS in primary splenocytes from 5-mo-old mice of 
various genotypes. Data shown are means and standard deviations derived from three mice per genotype. We counted the chromosomes of 
50 metaphase spreads per mouse. 100 spreads per mouse were screened for PMSCS.T
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Lastly, we would like to emphasize that our genetic study
does not exclude the possibility that Rae1 is essential for ex-
port of only a small subset of mRNAs.
Mechanism of checkpoint regulation by Rae1
In this study, we show that haplo-insufficiency of Rae1 re-
sults in a mitotic checkpoint defect and chromosome mis-
segregation. In addition, we show that Bub3 haplo-insuffi-
cient cells exhibit a strikingly similar mitotic phenotype,
suggesting that Rae1 may act in an analogous way to Bub3.
The finding that ectopic expression of Rae1 can correct not
only for Rae1 haplo-insufficiency but also for Bub3 haplo-
insufficiency strongly supports this conclusion. Although
the critical functions of Rae1 and Bub3 in checkpoint acti-
vation may be redundant, the finding that compound het-
erozygous knockout mice are viable whereas homozygous
Rae1 and Bub3 mice are embryonically lethal illustrates that
both proteins have a critical, nonredundant physiological
function as well.
What then could be the mechanism by which Rae1 regu-
lates the activity of the mitotic checkpoint and how may
Rae1 be able to compensate for Bub3 haplo-insufficiency?
Because Rae1 has been shown to localize to unattached kinet-
ochores at the onset of mitosis (Wang et al., 2001), it is pos-
sible that Rae1 might play a role in the production of ana-
phase wait signals at that position. Given that the checkpoint
protein Bub1 also targets to unattached kinetochores in mi-
tosis and can bind to Rae1 (Wang et al., 2001), it is further
possible that Rae1 and Bub1 might participate in such sig-
naling events as a protein complex. Interestingly, like Rae1,
Bub3 also targets to unattached kinetochores and interacts
with Bub1. We have shown that the GLEBS sequence of
Bub1 serves as a shared binding motif for Rae1 and Bub3
(Wang et al., 2001). Given that both Rae1–Bub1 and Bub3–
Bub1 complexes coexist in prometaphase-arrested HeLa cells
(Wang et al., 2001), one possible explanation for the pheno-
typic similarity between Rae1 and Bub3 haplo-insufficient
cells could be that Rae1–Bub1 and Bub3–Bub1 complexes
fulfill redundant functions at unattached kinetochores. Cor-
rection of the mitotic checkpoint in Bub3 haplo-insufficient
cells by overexpression of HA-tagged Rae1 could then simply
result from the assembly of “unbound” Bub1 molecules into
Rae1–Bub1 complexes that would be capable of performing
the functions of the missing Bub3–Bub1 complexes (Fig.
10). Bub3 also interacts with BubR1 (Taylor et al., 1998),
and Bub3–BubR1 complexes positioned in the mitotic cyto-
sol seem to play a critical role in inhibiting the APC (Fig. 10)
(Sudakin et al., 2001; Tang et al., 2001; Fang, 2002). Be-
cause Rae1 does not interact with BubR1 (Wang et al.,
2001), the mechanism by which Rae1 overexpression acts to
correct Bub3 haplo-insufficient cells is unlikely to involve
the formation of compensatory Rae1–BubR1.
Synergy between Rae1 and Bub3
Combined haplo-insufficiency of Rae1 and Bub3 causes a
much more severe chromosomal instability phenotype than
single haplo-insufficiency of either gene (Fig. 8). This find-
ing indicates that Rae1 cooperates with Bub3 and that the
combination of the two mitotic checkpoint activities is criti-
cal for the prevention of chromosomal missegregation. What
could be the mechanism of synergy between Rae1 and
Bub3? The fact that Rae1 can compensate for Bub3 haplo-
insufficiency suggests that Rae1 and Bub3 might be acting at
a common step of the checkpoint pathway (Hartman et al.,
2001), such as one that involves Rae1–Bub1 and Bub3–
Bub1 complexes at unattached kinetochores (Fig. 10). The
idea that the mechanism of synergy may involve Bub1 is
supported by a previous study of Basu et al. (1999) showing
that hypomorphic mutations in the Drosophila Bub1 gene
Figure 9. DMBA-induced tumor formation in checkpoint-defective 
mice. (A) Gross photograph of lung tumors of a DMBA-treated 
Rae1
 / /Bub3
 /  mouse (left), and a section of a Rae1
 / /Bub3
 /  
lung tumor (right; 10 , hematoxylin   eosin). Arrows point out the 
tumors. (B) The occurrence of lung tumors in 5-mo-old mice plotted 
as percentage incidence. The asterisk indicates P   0.05 compared 
with wild-type mice by Chi-squared test. We note that the tumor 
incidence of the checkpoint-defective group of mice as a whole is 
significantly increased relative to wild-type mice (P   0.05 by 
Chi-squared test). (C) The average number of lung adenomas per 
mouse ( SEM). The asterisks indicate P   0.05 compared with 
wild-type mice by Wilcoxon rank sum test.T
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cause a phenotype that has remarkable similarity to that of
Rae1/Bub3 mutants. The fact that we were unable to detect
protein complexes containing both Rae1 and Bub3 (Wang
et al., 2001) suggests that a physical interaction between
Rae1 and Bub3 may not be a requirement for their synergis-
tic action (Herschlag and Johnson, 1993).
Mitotic checkpoint defects and tumorigenesis
Similar to Rae1 and Bub3 haplo-insufficiency, Mad2 haplo-
insufficiency disturbs the mitotic checkpoint and causes
chromosomal instability (Michel et al., 2001). Thus, it ap-
pears that the mammalian mitotic spindle checkpoint is a
molecular backup system with exquisite sensitivity to events
causing subnormal expression of its components. The present
study shows that subnormal expression of Rae1 and/or Bub3
predisposes mice to carcinogen-induced lung tumors. In ad-
dition, a previous study has shown that mice with reduced
expression of Mad2 are prone to develop spontaneous lung
tumors after long latencies (Michel et al., 2001). Together,
these data suggest that decreased mitotic checkpoint protein
expression and tumor progression are causally related. Several
studies have shown that inactivating point mutations in mi-
totic checkpoint genes are rare in human tumors with chro-
mosomal instability (Cahill et al., 1998, 1999a; Hernando et
al., 2001). However, as epigenetic events or losses of whole
chromosomes are plausible mechanisms by which mitotic
checkpoint genes could be down-regulated, it is conceivable
that these events may actually play a more active role in can-
cers with chromosomal instability than point mutations.
Consistent with this idea, a recent study of the mitotic check-
point genes Bub1 and BubR1 showed that they are epigenet-
ically down-regulated in a substantial proportion of human
carcinomas (Shichiri et al., 2002). Further analysis of human
tumors for decreased expression of mitotic checkpoint regula-
tors such as Rae1 and Bub3 should provide important in-
sights into the causal relationship between mitotic checkpoint
gene activity and chromosomal instability.
Materials and methods
Generation of knockout mice and DMBA tumorigenic treatment
The Rae1 targeting vector contained a  9-kb Rae1 129Sv/J genomic DNA
fragment in which a unique EcoRV site was used to insert a promoterless
IRES-lacZ-neo selection cassette (van Deursen et al., 1996). Targeting mu-
tagenesis of ES cells was as previously described (van Deursen et al.,
1996). We identified targeted ES cell clones by Southern blot analysis us-
ing a 3  probe on BamHI-cut genomic DNA (Fig. 1 B). The Bub3 construct
contained an  8.5-kb Bub3 129Sv/J genomic DNA fragment in which a
1.4-kb SacI fragment was replaced by a pGKneo cassette (van Deursen et
al., 1996), interrupting the Bub3 gene at amino acid 191. Targeted ES cell
clones were identified by Southern blotting using a 5  probe on BamHI-cut
genomic DNA (Fig. 5, A and B). Mutant mice were derived from targeted
ES cell clones through standard procedures. DMBA treatment was as previ-
ously described (Serrano et al., 1996). All major organs were screened for
overt tumors using a dissection microscope. Harvested tumors were rou-
tinely processed for histopathological confirmation.
In vitro culture and PCR genotyping of blastocysts
Blastocysts were recovered from the uterine horns of plugged Rae1
 /  fe-
males at 3.5 d post-coitum and cultured in DME with 15% FCS on 10-well
microscope slides for 2–5 d. Processing of embryos and embryonic out-
growths for genotype analysis was performed as previously described in
detail (van Deursen et al., 1996). Sequences specific for the wild-type
Rae1 gene were amplified by using primer 1 (5 -GCCTTGTGCAAATGC-
CGCCCTTGG-3 ) and primer 2 (5 -TACATCATTCGCCCATGATCCTGC-
3 ), those specific for the knockout Rae1 allele were amplified with primer
combination 1 and 3 (5 -GGGCTGACCGCTTCCTCGTGCTTT-3 ). The re-
sulting PCR fragments measured 516 bp for the wild-type allele and 650
bp for the knockout allele.
Generation and culture of MEFs
MEFs were isolated from 13.5-d-old embryos as previously described (Ka-
mijo et al., 1997). We counted the seeding of trypsinized embryo car-
casses as passage 1 and the first replating as passage 2. Routine mainte-
nance of MEFs occurred according to a 3T9 schedule. Growth curves were
performed at passage 4. At day 0, 10
5 MEFs were plated per 3.5-mm-diam-
eter dish, and duplicate cultures were counted at 24-h intervals thereafter.
MEFs were synchronized as previously described (Cheng et al., 1999). In
brief, confluent cultures were washed three times with PBS and then cul-
tured in DME containing 0.1% FBS and 0.04% BSA for 18 h. Quiescent
MEFs were trypsinized and reseeded in DME with 10% FBS to allow their
reentry into the cell cycle.
Mitotic index and DNA profile analysis
To determine the mitotic index, MEF cells were plated in chambered mi-
croscope slides (5,000 cells per chamber of 0.4 cm
2). The next day, 200
ng/ml nocodazole (Michel et al., 2001) was added to the culture medium
for 0, 2, 6, 12, or 24 h. Subsequently, cells were immunostained with an
Figure 10. Model for Rae1 function in mitosis. We propose that 
Rae1 targets to unattached kinetochores at the onset of mitosis 
together with Bub1, just like Bub3. There, Rae1–Bub1 and Bub3–Bub1 
proteins act to activate the mitotic checkpoint, potentially by 
producing anaphase wait signals. Unlike Rae1, Bub3 also interacts 
with BubR1 and localizes to the cytosolic component of the mitotic 
checkpoint complex that acts to inhibit the APC activator Cdc20 
when anaphase wait signals are present. For simplicity, only part of 
the components of the checkpoint is shown in the model.T
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antibody against phospho-histone H3 (a commonly used marker for mitotic
cells) as previously described (Kasper et al., 1999). DNA was visualized by
Hoechst staining. Using a fluorescence microscope, we counted both the
number of Hoechst-stained nuclei and the number of anti-H3–positive
cells per well to calculate the mitotic index (defined as percentage of anti–
phospho-histone H3–positive cells). For DNA content analysis, adherent
and nonadherent MEF cells were pooled, washed with ice-cold PBS, fixed
in 95% ethanol, treated with 1 mg/ml RNase A, stained with 1 mg/ml pro-
pidium iodide, and subjected to flow cytometry as described previously
(Blajeski et al., 2002). For Rae1 correction experiments, we randomly se-
lected one wild-type, two Rae1
 / , and two Bub3
 /  MEF lines, immortal-
ized them with simian virus 40 large T antigen (this viral protein has no im-
pact on the mitotic checkpoint activity in the MEF lines used; Fig. 7), and
then transduced them with pMSCV-Puro-HA–Rae1 or pMSCV-Puro con-
taining retroviruses, as previously described in detail (Kasper et al., 1999).
Drug selection was in 1.25  g/ml puromycin (Sigma-Aldrich) for 5 d.
Karyotype analyses
To prepare metaphase spreads from MEFs, 1–2   10
6 cells (at passage 5)
were treated with 0.05  g/ml colcemid (GIBCO BRL) for 4–5 h at 37 C. To
prepare metaphase spreads from splenocytes (Rudolph et al., 1999),
spleens were freshly collected and minced between two microscope
slides. Released cells were suspended in 5 ml PBS, centrifuged at 1,000
rpm for 5 min, resuspended in 4 ml of RPMI containing 10% FBS, IL-2 (10
U/ml), PHA (5  g/ml), conA (5  g/ml), and colcemid (0.05  g/ml), and
cultured for 6–7 h at 37 C. After colcemid treatment, MEF or splenocyte
cells were harvested, suspended in 5 ml 0.075 M KCl, and incubated at RT
for 30 min. Cells were fixed in Carnoy’s solution (75% methanol, 25%
acetic acid), washed, and finally resuspended in  0.5 ml fixative. 25- l al-
iquots were dropped onto prewetted microscope slides, stained for 10 min
in 5% Giemsa solution, and analyzed on an Olympus AX70 microscope
using a 100  objective.
Western blot analysis, immunoprecipitation, 
and in vitro kinase assay
Western blot analyses were performed as previously described (Kasper et
al., 1999). Immunoprecipitation of cyclin B–associated Cdc2 and in vitro
kinase assays on histone H1 substrate were as previously described (Wass-
mann and Benezra, 1998).
Immunofluorescence and staining for poly(A)
  RNA
Immunostainings and poly(A)
  RNA detection were as previously de-
scribed (van Deursen et al., 1996). Anti-Tap antiserum (Braun et al., 1999)
was used in 1:500 dilution.
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